Related Experiment Video
Updated: Apr 24, 2026

Standardized In vitro Assays to Visualize and Quantify Interactions between Human Neutrophils and Staphylococcus aureus Biofilms
Published on: June 8, 2022
Pfs promotes autolysis-dependent release of eDNA and biofilm formation in Staphylococcus aureus
1Department of Microbiology and Immunology, School of Life Sciences, University of Science and Technology of China, Hefei, 230027, Anhui, China.
Abstract:
Staphylococcus aureus is a major biofilm-forming pathogen, and biofilm formation remains an obstacle in the treatment of clinical S. aureus infection. Methylthioadenosine/S-adenosylhomocysteine nucleosidase (Pfs) has been implicated in methylation reactions, polyamine synthesis, vitamin synthesis, and quorum-sensing pathways. In this study, we observed that the deletion of pfs gene in S. aureus NCTC8325 reduced bacterial clumping ability and resulted in the decreased biofilm formation under both static and dynamic flow conditions in an autoinducer-2-independent manner. While the PIA amount was not affected, the pfs mutation significantly decreased the amount of eDNA present in the biofilm and the cell autolysis. Consistent with reduced autolysis, the transcription levels of the autolysin genes, lytM and atlE, were reduced in the absence of Pfs. These data suggest that Pfs promotes autolysis-dependent release of eDNA and biofilm formation in S. aureus, and our findings indicate that Pfs is a potential novel target for anti-biofilm therapy.
Insights
The Pfs enzyme is crucial for Staphylococcus aureus biofilm formation by promoting cell lysis and extracellular DNA release. Targeting Pfs could be a novel strategy for anti-biofilm therapies against S. aureus infections.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Staphylococcus aureus is a significant pathogen known for forming biofilms, which complicates clinical treatments.
- Biofilm formation is a key virulence factor for S. aureus, contributing to persistent and difficult-to-treat infections.
- The enzyme Methylthioadenosine/S-adenosylhomocysteine nucleosidase (Pfs) is involved in various metabolic and signaling pathways.
Purpose of the Study:
- To investigate the role of the Pfs enzyme in Staphylococcus aureus biofilm formation.
- To elucidate the mechanisms by which Pfs influences biofilm development.
- To evaluate Pfs as a potential therapeutic target for combating S. aureus biofilms.
Main Methods:
- Gene deletion of pfs in S. aureus NCTC8325.
- Assessment of bacterial clumping and biofilm formation under static and dynamic conditions.
- Quantification of poly-N-acetylglucosamine (PIA) and extracellular DNA (eDNA) in biofilms.
- Analysis of cell autolysis and transcription levels of autolysin genes (lytM, atlE).
Main Results:
- Deletion of the pfs gene significantly reduced S. aureus clumping and biofilm formation.
- The pfs mutation decreased extracellular DNA (eDNA) levels within biofilms.
- Reduced cell autolysis and decreased transcription of autolysin genes (lytM, atlE) were observed in the pfs mutant.
- Biofilm reduction occurred independently of the autoinducer-2 quorum-sensing pathway.
Conclusions:
- Pfs plays a critical role in promoting Staphylococcus aureus biofilm formation through an autolysis-dependent mechanism involving eDNA release.
- The Pfs enzyme is a potential novel therapeutic target for developing anti-biofilm strategies against S. aureus infections.
Related Concept Videos
Staphylococcal Skin Infections
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Mechanism of Antibiotic Resistance in MRSA

